Dr. Chao H. Huang
Claim this profileUniversity of Kansas Health System Saint Francis Campus
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
22 reported clinical trials
35 drugs studied
About Chao H. Huang
Education:
- Completed preparatory studies at Colegio Rosario, Porto Alegre, Rio Grande do Sul.
- Earned an MD from Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul.
Experience:
- Completed an Internship and Residency in Internal Medicine at Presbyterian Medical Center of the University of Pennsylvania Health System, Philadelphia, PA.
- Undertook a Clinical Fellowship in Hematology & Medical Oncology at Fox Chase Cancer Center and Temple University Hospital.
- Actively involved in teaching and mentoring at the University of Kansas Health System Saint Francis Campus, specializing in lung cancer and head and neck cancer.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Chao H. Huang is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
More about Chao H. Huang
Clinical Trial Related5 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Chao H. Huang has experience with
- Pembrolizumab
- Carboplatin
- Pemetrexed
- Ramucirumab
- Biospecimen Collection
- Selpercatinib
Breakdown of trials Chao H. Huang has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Relapse
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chao H. Huang specialize in?
Chao H. Huang focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Chao H. Huang currently recruiting for clinical trials?
Yes, Chao H. Huang is currently recruiting for 8 clinical trials in Topeka Kansas. If you're interested in participating, you should apply.
Are there any treatments that Chao H. Huang has studied deeply?
Yes, Chao H. Huang has studied treatments such as Pembrolizumab, Carboplatin, Pemetrexed.
What is the best way to schedule an appointment with Chao H. Huang?
Apply for one of the trials that Chao H. Huang is conducting.
What is the office address of Chao H. Huang?
The office of Chao H. Huang is located at: University of Kansas Health System Saint Francis Campus, Topeka, Kansas 66606 United States. This is the address for their practice at the University of Kansas Health System Saint Francis Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.